Skip to content
Every Face Matters LogoEvery Face Matters
Meta-AnalysisJackson et al., Sleep Medicine, 2019

Depression and Untreated Sleep Apnoea

Space to Sleep Well
Published 20191 min read

Mood and sleep are deeply entangled, but how often does genuine clinical depression accompany untreated obstructive sleep apnoea? This meta-analysis set out to answer that with rigour, pooling studies that used standardised clinical assessment — not just casual symptom questionnaires — to measure the prevalence of depression and antidepressant use in people whose apnoea had not been treated.

Beyond counting cases, the authors examined which factors predicted depression among OSA patients, trying to understand who is most vulnerable. Insisting on formal diagnostic assessment is what separates this from softer associations; it counts depression as clinicians would actually diagnose it.

This matters because it widens the reach of disordered breathing into mental health. The same fragmented, oxygen-starved sleep that dulls thinking also weighs on mood. A person treated for depression whose underlying sleep apnoea goes unrecognised may be fighting the wrong battle. Surfacing this link is part of the project's broader argument: that the airway touches far more of human function than most clinical specialties account for.

Key Findings

  • A meta-analysis examined the prevalence of clinical depression and antidepressant use among people with untreated obstructive sleep apnoea.

  • Patients with OSA experience daytime sleepiness, cognitive impairment, and depressive symptoms.

  • It uses standardised clinical assessment of depression rather than informal symptom checklists.

We’re advocates, not clinicians. This is curated, sourced evidence to help you ask better questions — bring it to a professional you trust, not a substitute for their advice.

Help the mission

Share this evidence so more people can ask better questions.

Sign in and earn a point every time you share.